Alimera Sciences Inc. is a biopharmaceutical company that engaged in the research development and commercialization of ophthalmic pharmaceuticals.


Updates from The Motley Fool

Latest updates on Alimera Sciences from Fool.com.


Stock Performance

View Interactive ALIM Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alimera Sciences.
Current Price: $1.26
Prev Close: $1.23
Open: $1.20
Bid: $1.23
Ask: $1.27
Day's Range: $1.16 - $1.26
52wk Range: $1.02 - $5.15
Volume: 540,929
Avg Vol 716,172
Market Cap: $82M
P/E (ttm): -1.54
EPS (ttm): ($0.80)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alimera Sciences.
CAPS Rating 2 out of 5
 
66 Outperform
17 Underperform
CAPS All Stars
 
6 Outperform
7 Underperform

How do you think Alimera Sciences will perform against the market?



You pick for Alimera Sciences is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

C. Daniel Myers, CEO

100% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alimera Sciences.

Alimera Sciences Inc. is a biopharmaceutical company that engaged in the research development and commercialization of ophthalmic pharmaceuticals.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers